Financial statements Lux Pharm
Balance sheet data of LUX PHARM
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 582 484,36 | 899 360,38 | 1 347 195,64 | 1 557 426,99 |
| A. Fixed assets | 50 906,99 | 41 455,67 | 32 648,98 | 25 775,62 |
| B. Current assets | 531 577,37 | 857 904,71 | 1 314 546,66 | 1 531 651,37 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 582 484,36 | 899 360,38 | 1 347 195,64 | 1 557 426,99 |
| A. Equity | 210 101,09 | 528 997,18 | 859 251,94 | 1 011 642,72 |
| B. Liabilities and provisions for liabilities | 372 383,27 | 370 363,20 | 487 943,70 | 545 784,27 |
| I. Long-term liabilities | 0,00 | - | - | - |
| II. Short-term liabilities | 372 383,27 | - | - | 530 784,27 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.